Home/Cessation Therapeutics/Admiral James “Sandy” Winnefeld
AJ

Admiral James “Sandy” Winnefeld

Strategic Advisor (Volunteer), USN Retired, Former Vice Chairman of the Joint Chiefs of Staff

Cessation Therapeutics

Cessation Therapeutics Pipeline

DrugIndicationPhase
Anti-fentanyl monoclonal antibody (CSX-1004 inferred)Prevention of fentanyl overdosePhase 1